Ramon E. Camacho
Merck & Co., Inc., Rahway, NJ, USA (United States)(US)
Publications by Year
Research Areas
Regulation of Appetite and Obesity, Biochemical Analysis and Sensing Techniques, T-cell and B-cell Immunology, Signaling Pathways in Disease, Lung Cancer Treatments and Mutations
Most-Cited Works
- → Inactivation of the mouse melanocortin-3 receptor results in increased fat mass and reduced lean body mass(2000)892 cited
- → Melanin-concentrating hormone 1 receptor-deficient mice are lean, hyperactive, and hyperphagic and have altered metabolism(2002)547 cited
- → Neither Agouti-Related Protein nor Neuropeptide Y Is Critically Required for the Regulation of Energy Homeostasis in Mice(2002)419 cited
- → Role of the melanocortin-4 receptor in metabolic rate and food intake in mice(2000)247 cited
- → Inhibition of T Cell Activation by Pharmacologic Disruption of the MEK1/ERK MAP Kinase or Calcineurin Signaling Pathways Results in Differential Modulation of Cytokine Production(1998)187 cited
- → Chronic MCH-1 receptor modulation alters appetite, body weight and adiposity in rats(2003)185 cited
- → Immune Enhancing Effect of a Growth Hormone Secretagogue(2001)113 cited
- → Real-World Treatment Patterns, Overall Survival, and Occurrence and Costs of Adverse Events Associated With First-line Therapies for Medicare Patients 65 Years and Older With Advanced Non–small-cell Lung Cancer: A Retrospective Study(2018)53 cited
- → Plasma Agouti‐Related Protein Level: A Possible Correlation with Fasted and Fed States in Humans and Rats(2002)52 cited
- → Real-World Treatment Patterns, Overall Survival, and Occurrence and Costs of Adverse Events Associated With Second-Line Therapies for Medicare Patients With Advanced Non–Small-Cell Lung Cancer(2018)49 cited